Filing Flows › Vycor Medical (VYCO) › Q3 2025
Vycor Medical (VYCO) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 14, 2025
Vycor Medical (VYCO) reported revenue of $514K for the third quarter 2025 (Q3 2025), +31% from a year earlier and +4% from the quarter before. Operating margin was 6.2%, net earnings $5K (1.0% of revenue).
Vycor Medical, Q3 2025: revenue $514K (+32% year over year), operating margin 6.2%, net earnings $5K, operating cash flow −$72K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $514K | +4% | +31% |
| Gross profit | $452K | +9% | +28% |
| Operating profit | $32K | -37% | — |
| Net earnings | $5K | -79% | — |
| Operating cash flow | −$72K | -255% | — |
What changed
Revenue was $514K in Q3 2025, up 31% year over year and up 4% from the previous quarter. Vycor Medical Inc was the largest line at 96% of revenue. Vycor Medical Inc added $119K year over year (up 32%), 97% of the total change.
Gross margin was 88.0%, down 2.6 points from a year earlier. Operating profit was $32K, a 6.2% margin (up 15.2 points year over year). Operating expenses grew 8% against revenue growth of 31%. The fastest-growing cost line was SG&A (+10%). Net earnings were $5K. The effective tax rate was 1.1%.
Operating cash flow was −$72K. Non-cash charges added back $15K of depreciation and amortization and $12K of share-based compensation. Working capital and other items used $104K. Capital expenditures of $0K exceeded it, leaving free cash flow of −$72K.
Questions
What was Vycor Medical's revenue in the third quarter 2025?
Vycor Medical (VYCO) reported revenue of $514K for the third quarter 2025 (Q3 2025), +31% from a year earlier and +4% from the quarter before.
Was Vycor Medical profitable in the third quarter 2025?
Operating profit was $32K (6.2% of revenue) and net earnings $5K.
Source: Vycor Medical 10-Q on SEC EDGAR.